Goldman Sachs Group Inc Boston Scientific Corp Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 14,666,468 shares of BSX stock, worth $1.11 Billion. This represents 0.18% of its overall portfolio holdings.
Number of Shares
14,666,468
Previous 16,026,493
8.49%
Holding current value
$1.11 Billion
Previous $926 Million
8.42%
% of portfolio
0.18%
Previous 0.17%
Shares
17 transactions
Others Institutions Holding BSX
# of Institutions
1,319Shares Held
1.17BCall Options Held
5.92MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA127MShares$9.63 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY127MShares$9.58 Billion0.21% of portfolio
-
State Street Corp Boston, MA62.7MShares$4.74 Billion0.19% of portfolio
-
Massachusetts Financial Services CO Boston, MA46.6MShares$3.52 Billion0.99% of portfolio
-
Primecap Management CO Pasadena, CA37.9MShares$2.87 Billion1.97% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $108B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...